Annual Review of Virology

Scope & Guideline

Shaping the future of virology through scholarly excellence.

Introduction

Welcome to the Annual Review of Virology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Annual Review of Virology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2327-056x
PublisherANNUAL REVIEWS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2014 to 2023
AbbreviationANNU REV VIROL / Annu. Rev. Virol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139

Aims and Scopes

The Annual Review of Virology serves as a comprehensive resource for the latest advancements in the field of virology, encompassing a wide range of topics from molecular biology to ecological impacts. The journal focuses on synthesizing and summarizing significant research findings, methodologies, and theoretical frameworks in virology.
  1. Molecular Virology:
    Exploration of viral structure, function, and replication mechanisms, including studies on viral proteins, RNA synthesis, and genetic systems.
  2. Host-Virus Interactions:
    Investigation of how viruses interact with their hosts, including immune evasion strategies, host cell responses, and the role of microbiomes in viral infections.
  3. Viral Pathogenesis and Disease:
    Analysis of the mechanisms through which viruses cause diseases in various hosts, alongside discussions on therapeutic interventions and vaccine development.
  4. Ecological and Evolutionary Virology:
    Examination of viruses in ecological contexts, including their roles in ecosystems, evolutionary dynamics, and their interactions with different biological systems.
  5. Innovative Therapeutic Approaches:
    Research into novel antiviral strategies, including phage therapy, RNA-based vaccines, and the development of agents targeting viral processes.
The Annual Review of Virology has seen a notable evolution in its thematic focus, with several emerging trends reflecting the current landscape of virology research. This section outlines the key themes that are gaining traction in recent publications.
  1. Microbiome-Virus Interactions:
    A rising interest in how the microbiome influences viral infections and immune responses, highlighting the complex interplay between host-associated microbes and viral pathogens.
  2. Advancements in Vaccine Technology:
    Increased focus on innovative vaccine strategies, including mRNA technology and plant-based vaccines, driven by the urgent need for effective responses to emerging viral threats.
  3. Viral Evolution and Ecology:
    Growing attention to the ecological impacts of viruses and their evolutionary trajectories, emphasizing their roles in shaping host populations and ecosystems.
  4. Phage Therapy and Antiviral Strategies:
    Emerging research into bacteriophage applications as therapeutic agents against bacterial infections, reflecting a shift towards alternative treatments in the face of antibiotic resistance.
  5. Structural Insights into Viral Mechanisms:
    Enhanced emphasis on structural biology studies to elucidate viral functions and interactions at the molecular level, aiding in the development of targeted therapeutics.

Declining or Waning

While the Annual Review of Virology has maintained a broad focus, certain themes have shown a decline in prominence over recent years. This section highlights areas that are becoming less frequent in the journal's publications.
  1. Traditional Plant Virology:
    Topics focusing on conventional plant viruses and their interactions with crops are becoming less prevalent, possibly due to an increased interest in broader ecological and evolutionary considerations.
  2. Historical Perspectives on Virology:
    While historical insights have been valuable, recent publications suggest a shift towards more contemporary and applied research, reducing the emphasis on retrospective analyses.
  3. Basic Virus Classification Studies:
    Research primarily aimed at classifying new viruses without exploring their functional implications appears to be waning, as the field moves towards more integrative and systems biology approaches.

Similar Journals

ANTIVIRAL THERAPY

Transforming the landscape of antiviral pharmacology.
Publisher: SAGE PUBLICATIONS LTDISSN: 1359-6535Frequency: 8 issues/year

ANTIVIRAL THERAPY is a prominent academic journal dedicated to the field of infectious diseases and pharmacology, published by SAGE Publications Ltd in the United Kingdom. Since its inception in 1996, this journal has become an essential platform for disseminating cutting-edge research and innovative therapeutic approaches for viral infections, making significant contributions to advancements in medical science. With an HIndex indicating the quality and influence of its published work, ANTIVIRAL THERAPY holds prestigious rankings in its categories, including Q3 in Infectious Diseases and Pharmacology as of 2023. While it currently does not offer open access, the journal provides valuable insights that are crucial for researchers, healthcare professionals, and students engaged in antiviral research and treatment strategies. As it converges towards 2024, the journal continues to play a vital role in shaping the understanding and management of viral diseases, making it a critical resource for anyone involved in this important field of study.

VIROLOGIE

Connecting researchers in the global virology community.
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 1267-8694Frequency: 6 issues/year

VIROLOGIE is a prominent international journal dedicated to advancing the field of virology and infectious diseases, published by John Libbey Eurotext Ltd. Since its inception in 1997, this journal has provided a platform for researchers and professionals to disseminate their findings on various aspects of virology, including the pathogenesis, epidemiology, and treatment of viral infections. Despite its current ranking in Q4 for both Infectious Diseases and Virology categories, the journal remains a valuable resource for emerging research and novel insights. The ISSN for the journal is 1267-8694, and it is based in France. VIROLOGIE is committed to upholding rigorous academic standards and fosters an inclusive scholarly community, making it an essential read for those pursuing knowledge and advancements in the ever-evolving landscape of virology. While the journal does not currently offer open access options, it continues to contribute significantly to the global discourse on viral research through its diverse range of published studies.

VIROLOGICA SINICA

Bridging Knowledge Gaps in Virology and Human Health
Publisher: KEAI PUBLISHING LTDISSN: 1674-0769Frequency: 6 issues/year

VIROLOGICA SINICA, published by KEAI PUBLISHING LTD, is a leading international journal dedicated to the field of virology. With an ISSN of 1674-0769 and E-ISSN of 1995-820X, this esteemed journal showcases cutting-edge research from 2006 to 2024, focusing on critical developments in Immunology, Infectious Diseases, Molecular Medicine, and Virology. As evidenced by its respectable positioning in the Q2 quartile of relevant categories and impressive Scopus rankings—such as Rank #20/80 in Virology—VIROLOGICA SINICA serves as an essential resource for researchers, professionals, and students aiming to deepen their understanding of viral pathogens and their impact on human health. While the journal does not currently offer open access, it remains an invaluable publication for those seeking to stay at the forefront of virology research. Its address is located at 16 Donghuangchenggen North St, Beijing, China, where it continues to foster academic excellence in the rapidly evolving landscape of virology.

Retrovirology

Pioneering Discoveries in Virology and Beyond
Publisher: BMCISSN: Frequency: 1 issue/year

Retrovirology is a prominent open-access journal published by BMC since 2004, dedicated to the field of retroviral research. With a strong focus on advancing knowledge in both infectious diseases and virology, this interdisciplinary journal has achieved a commendable ranking of Q2 in its respective categories as of 2023, reflecting its significant contribution to the scientific community. Hosted in the United Kingdom, Retrovirology serves a global audience of researchers, professionals, and students, making vital research accessible to all without barriers. The journal's emphasis on high-quality peer-reviewed articles supports the dissemination of groundbreaking findings that could shape the future of virology and related fields. With an impressive Scopus ranking, including a percentile of 65th in Medicine: Infectious Diseases, it stands out as a valuable resource for those committed to understanding and combating viral diseases. Retrovirology continues to be an essential platform for innovative research, with its open-access model ensuring that transformational science reaches the widest possible audience.

VIRAL IMMUNOLOGY

Pioneering insights into viral immunology for a healthier future.
Publisher: MARY ANN LIEBERT, INCISSN: 0882-8245Frequency: 10 issues/year

Viral Immunology, published by Mary Ann Liebert, Inc, stands as a prominent journal dedicated to advancing the understanding of the interplay between viral infections and host immune responses. With a strong focus on immunology, molecular medicine, and virology, the journal provides a platform for the dissemination of high-quality research findings and innovative methodologies that could shape the future of these critical fields. Although it currently holds a Q3 rating across its relevant categories and a respectable ranking within the Scopus database, Viral Immunology continues to strive for excellence with a commitment to publishing influential research that informs both academic and clinical practices. The journal accepts submissions in various formats—original research, reviews, and commentaries—catering to a diverse readership that includes researchers, professionals, and students engaged in the biological and medical sciences. Readers can anticipate insightful articles that address urgent challenges in immunological responses to viral infections, paving the way for new therapeutic strategies and public health initiatives.

VIROLOGY

Your Gateway to Cutting-Edge Virology Insights
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0042-6822Frequency: 13 issues/year

Virology, published by Academic Press Inc. Elsevier Science, is a prominent journal dedicated to advancing the knowledge and understanding of viral biology and pathogenesis since its inception in 1955. With a distinguished impact factor and recognized as a Q2 journal in the field of Virology for 2023, it ranks 38 out of 80 in the Scopus database for Immunology and Microbiology, placing it in the 53rd percentile among similar publications. This esteemed journal provides a platform for groundbreaking research, critical reviews, and comprehensive studies that contribute to our global understanding of viruses and their impact on health and disease. Although currently not an open-access journal, it remains accessible to a wide audience of researchers, professionals, and students who are keen to explore the latest advancements in virological research. The journal's scope encompasses a diverse range of topics, ensuring that it serves as an essential resource for anyone engaged in virology and related biomedical fields.

VIRUS RESEARCH

Connecting discoveries in virus biology and medicine.
Publisher: ELSEVIERISSN: 0168-1702Frequency: 12 issues/year

VIRUS RESEARCH is a leading journal dedicated to the field of virology, published by Elsevier, and has been a cornerstone for researchers, professionals, and students since its inception in 1984. With an impressive impact factor, the journal is highly regarded, holding a Q2 category ranking in both Cancer Research and Infectious Diseases, as well as in Virology for 2023. Based in the Netherlands, it publishes high-quality, peer-reviewed articles that explore the intricate relationships between viruses and their hosts, novel therapeutic strategies, and advancements in virus biology. Researchers will find that it ranks 49th in Medicine - Infectious Diseases and 19th in Immunology and Microbiology - Virology according to Scopus, signifying its significant contribution and relevance in the academic world. VIRUS RESEARCH facilitates a platform for sharing groundbreaking discoveries, forming a vital part of the global scientific community, making it an essential read for those involved in the study of viral pathogens and their implications in medicine and biochemistry.

Virology Journal

Driving knowledge forward in the fight against viral diseases.
Publisher: BMCISSN: Frequency: 1 issue/year

Virology Journal, published by BMC, stands as a prominent open-access platform since 2004, dedicated to advancing the field of virology and infectious diseases. With its E-ISSN: 1743-422X, this journal is based in the United Kingdom and strives to disseminate high-quality research that enhances our understanding of viral pathogens and their interactions with hosts. Recognized with a Q1 classification in the category of Infectious Diseases and a Q2 in Virology for 2023, Virology Journal holds significant standing in the academic community, ranking #82/344 in Medicine - Infectious Diseases and #26/80 in Immunology and Microbiology - Virology. Its commitment to open access ensures that cutting-edge research is freely available to researchers, professionals, and students worldwide, fostering collaboration and innovation in the fight against viral diseases. The journal aims to publish original research articles, reviews, and commentaries that will stimulate discourse and spark new ideas within the virology community.

Journal of Clinical Virology Plus

Innovating the landscape of clinical virology research.
Publisher: ELSEVIERISSN: 2667-0380Frequency: 4 issues/year

The Journal of Clinical Virology Plus, published by Elsevier, is an essential resource for researchers and professionals in the fields of virology and infectious diseases. Launched in 2021, this journal aims to bridge the gap between clinical research and application, fostering a deeper understanding of viral pathogenesis, diagnostics, and therapeutic strategies. With an ISSN of 2667-0380, this open-access journal brings cutting-edge findings to the global scientific community, facilitating the rapid dissemination of knowledge critical for advancing public health. Positioned in the Q3 category for both Infectious Diseases and Virology in 2023, its ranking reflects its growing influence and relevance in the academic landscape. The journal strives to support innovative research, collaborative studies, and comprehensive reviews that address contemporary challenges in clinical virology. As it converges through the years from 2021 to 2024, Journal of Clinical Virology Plus aims to be a central hub for vital discussions and breakthroughs in this dynamic field.

Frontiers in Virology

Advancing the Frontiers of Viral Research
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Virology, published by FRONTIERS MEDIA SA, is an innovative open-access journal dedicated to advancing the understanding of viral biology, pathogenesis, surveillance, and control strategies. With the rapid evolution of viral threats, this journal serves as a critical platform for researchers, professionals, and students to disseminate and access high-quality research, reviews, and perspectives in virology. The journal places a strong emphasis on interdisciplinary approaches, promoting collaborative efforts that drive breakthroughs in the field. While the specific impact factor and H-index details are currently unavailable, Frontiers in Virology is committed to rigorous peer review and integrity in scientific publishing. Authors and readers will benefit from the extensive reach provided by open access, making groundbreaking insights available to a global audience, thus contributing significantly to the ongoing dialogue in virology and public health.